Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Genocea Commences Phase 2 Dose Optimization Trial For GEN-003 HSV-2 Immunotherapy

 

Genocea Commences Phase 2 Dose Optimization Trial For GEN-003 HSV-2 Immunotherapy

2014-07-30 09:52:30| drugdiscoveryonline Home Page

Genocea Biosciences, Inc. a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, recently announced the start of a Phase 2 dose optimization trial for GEN-003, the Company’s immunotherapy candidate against herpes simplex-type 2 (HSV-2)

Tags: trial phase dose optimization

Category:Biotechnology and Pharmaceuticals

Latest from this category	All news
»	24.11 Costume 24.11 BB S604ULS 24.11 33 24.11 ElectronicAudioExperimentsDude Incedible 24.11 TC101 5IP 6 NS.NEO 950GH S 24.11 24.11 24.11 More »